The Gastrointestinal Cancer Channel is supported with funding from Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESSO 45 | Why laparoscopic surgery remains viable for colorectal cancer in India
Murtaza Makasarwala, MBBS, FACS, Shalby Multispecialty Hospital, Surat, India, comments on the benefits and trade-offs of robotic and laparoscopic surgery in colorectal cancer, highlighting that while robotic surgery offers improved precision and visualization, laparoscopic surgery is still a viable and effective option, particularly in resource-constrained settings like India. A patient-centered approach is important, where the choice of surgical method is tailored to the individual patient’s needs, and notes that a well-trained surgeon can achieve excellent outcomes with either technique. This interview took place at the 2026 European Society of Surgical Oncology (ESSO) Annual Meeting in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
